1. Home
  2. INBK vs GLSI Comparison

INBK vs GLSI Comparison

Compare INBK & GLSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Internet Bancorp

INBK

First Internet Bancorp

N/A

Current Price

$27.11

Market Cap

255.0M

Sector

Finance

ML Signal

N/A

Logo Greenwich LifeSciences Inc.

GLSI

Greenwich LifeSciences Inc.

N/A

Current Price

$17.35

Market Cap

254.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
INBK
GLSI
Founded
1999
2006
Country
United States
United States
Employees
N/A
13
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
255.0M
254.7M
IPO Year
2013
2020

Fundamental Metrics

Financial Performance
Metric
INBK
GLSI
Price
$27.11
$17.35
Analyst Decision
Buy
Strong Buy
Analyst Count
5
2
Target Price
$30.90
★ $57.00
AVG Volume (30 Days)
37.0K
★ 88.7K
Earning Date
10-21-2026
11-13-2026
Dividend Yield
★ 0.91%
N/A
EPS Growth
N/A
★ N/A
EPS
★ 0.55
N/A
Revenue
★ $11,541,000.00
N/A
Revenue This Year
$18.94
N/A
Revenue Next Year
$14.34
N/A
P/E Ratio
$47.40
★ N/A
Revenue Growth
★ 101.84
N/A
52 Week Low
$17.05
$7.78
52 Week High
$31.09
$34.10

Technical Indicators

Market Signals
Indicator
INBK
GLSI
Relative Strength Index (RSI) 39.74 54.23
Support Level $25.04 $17.96
Resistance Level $30.04 $19.97
Average True Range (ATR) 0.89 1.30
MACD -0.16 0.08
Stochastic Oscillator 40.87 55.64

Price Performance

Historical Comparison
INBK
GLSI

About INBK First Internet Bancorp

First Internet Bancorp is a bank holding company. Through its subsidiaries, it provides commercial real estate (CRE) lending, including nationwide single tenant lease financing and commercial and industrial (C&I) lending, including business banking or treasury management services. The company offers its products and services through the internet and does not have any branches. With operations organized into a single segment called the Commercial Banking segment, it also provides retail banking services.

About GLSI Greenwich LifeSciences Inc.

Greenwich LifeSciences Inc a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, Flamingo-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences. GP2 is a 9-amino-acid transmembrane peptide of the HER2/neu protein, a cell surface receptor protein that is expressed in a variety of common cancers, including breast cancers at low (1+), intermediate (2+), and high (3+ or overexpressing) levels.

Share on Social Networks: